| IL‐6 up‐regulates Mcl‐1 in human myeloma cells through JAK/STAT rather than Ras/MAP kinase pathway D Puthier, R Bataille, M Amiot European journal of immunology 29 (12), 3945-3950, 1999 | 345 | 1999 |
| Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2 C Sapet, S Simoncini, B Loriod, D Puthier, J Sampol, C Nguyen, ... Blood 108 (6), 1868-1876, 2006 | 303 | 2006 |
| Genome-wide characterization of mammalian promoters with distal enhancer functions LTM Dao, AO Galindo-Albarrán, JA Castro-Mondragon, C Andrieu-Soler, ... Nature genetics 49 (7), 1073-1081, 2017 | 259 | 2017 |
| High incidence of N and K‐Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis S Bezieau, MC Devilder, H Avet‐Loiseau, MP Mellerin, D Puthier, ... Human mutation 18 (3), 212-224, 2001 | 256 | 2001 |
| The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma C Pellat-Deceunynck, S Barille, G Jego, D Puthier, N Robillard, D Pineau, ... Leukemia 12 (12), 1977-1982, 1998 | 256 | 1998 |
| Dynamic competing histone H4 K5K8 acetylation and butyrylation are hallmarks of highly active gene promoters A Goudarzi, D Zhang, H Huang, S Barral, OK Kwon, S Qi, Z Tang, ... Molecular cell 62 (2), 169-180, 2016 | 241 | 2016 |
| Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells G Jego, N Robillard, D Puthier, M Amiot, F Accard, D Pineau, ... Blood, The Journal of the American Society of Hematology 94 (2), 701-712, 1999 | 235 | 1999 |
| Mcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cells D Puthier, S Derenne, S Barillé, P Moreau, JL Harousseau, R Bataille, ... British journal of haematology 107 (2), 392-395, 1999 | 197 | 1999 |
| Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients CVA Collares, AF Evangelista, DJ Xavier, DM Rassi, T Arns, ... BMC research notes 6, 1-15, 2013 | 190 | 2013 |
| Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization C Pellat-Deceunynck, S Barillé, D Puthier, MJ Rapp, JL Harousseau, ... Cancer Research 55 (16), 3647-3653, 1995 | 189 | 1995 |
| High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals Y Le Priol, D Puthier, C Lécureuil, C Combadiere, P Debré, C Nguyen, ... The Journal of Immunology 177 (8), 5145-5154, 2006 | 161 | 2006 |
| CD28, a marker associated with tumoral expansion in multiple myeloma. N Robillard, G Jego, C Pellat-Deceunynck, D Pineau, D Puthier, ... Clinical cancer research: an official journal of the American Association …, 1998 | 148 | 1998 |
| Histone variant H2A. L. 2 guides transition protein-dependent protamine assembly in male germ cells S Barral, Y Morozumi, H Tanaka, E Montellier, J Govin, M de Dieuleveult, ... Molecular cell 66 (1), 89-101. e8, 2017 | 140 | 2017 |
| Drosophila microbiota modulates host metabolic gene expression via IMD/NF-κB signaling BE Combe, A Defaye, N Bozonnet, D Puthier, J Royet, F Leulier PloS one 9 (4), e94729, 2014 | 134 | 2014 |
| Divergent transcription is associated with promoters of transcriptional regulators C Lepoivre, M Belhocine, A Bergon, A Griffon, M Yammine, L Vanhille, ... BMC genomics 14, 1-20, 2013 | 121 | 2013 |
| Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV F Boutboul, D Puthier, V Appay, O Pellé, H Ait-Mohand, B Combadière, ... Aids 19 (17), 1981-1986, 2005 | 118 | 2005 |
| CD8 T cell help for innate antitumor immunity A Shanker, G Verdeil, M Buferne, EM Inderberg-Suso, D Puthier, F Joly, ... The Journal of Immunology 179 (10), 6651-6662, 2007 | 112 | 2007 |
| Functions of lncRNA in development and diseases EL Mathieu, M Belhocine, LT Dao, D Puthier, S Spicuglia Medecine Sciences: M/S 30 (8-9), 790-796, 2014 | 102 | 2014 |
| STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors G Verdeil, D Puthier, C Nguyen, AM Schmitt-Verhulst, N Auphan-Anezin The Journal of Immunology 176 (8), 4834-4842, 2006 | 102 | 2006 |
| Interferon α extends the survival of human myeloma cells through an upregulation of the Mcl‐1 anti‐apoptotic molecule D Puthier, W Thabard, MJ Rapp, M Etrillard, JL Harousseau, R Bataille, ... British journal of haematology 112 (2), 358-363, 2001 | 91 | 2001 |
Catherine Pellat-DeceunynckCRCINA INSERM 1232 CNRS 6001Verified email at inserm.fr
